You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Participants in the pilot will begin developing the capabilities required for the planned data commons, including making data transparent and interoperable.
Participants in the round included both new and existing investors.
The resource will offer easy access to an inventory of vendors with patient-derived xenograph models as well as associated molecular data for oncology drug discovery projects.
Repositive's platform, which is currently in beta testing, will include information from Xpressomics' data repositories.
The company will use the funds to further develop software for sharing genomic data, and to initiate research collaborations.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.